Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Isosorbide mononitrate
Drug ID BADD_D01211
Description Isosorbide mononitrate is an organic nitrate with vasodilating properties. It is an anti-anginal agent that works by relaxing the smooth muscles of both arteries and veins, but but predominantly veins to reduce cardiac preload.[L11698, L11743] Isosorbide mononitrate is an active metabolite of [isosorbide dinitrate]. Like other organic nitrates, isosorbide mononitrate acts as a prodrug for its active metabolite, [nitric oxide], which mediates the therapeutic action of isosorbide mononitrate.[L11743] Isosorbide mononitrate has a longer duration of action than [nitroglycerin] due to its slow onset of absorption and metabolism.[T28] First approved by the FDA in 1991,[L11743] isosorbide mononitrate is used for the prevention and management of angina pectoris caused by coronary artery disease; however, the onset of action of orally-administered isosorbide mononitrate is not rapid enough to offset an acute anginal episode.[L11698] It is available in oral tablets generically and under the brand name ISMO and Monoket. The extended-release forms of the drug are also available generically and under the brand name Imdur.[L11743]
Indications and Usage Isosorbide mononitrate is indicated for the prevention and management of angina pectoris due to coronary artery disease. The onset of action of oral isosorbide mononitrate is not sufficiently rapid to be useful in aborting an acute anginal episode.[L11698]
Marketing Status approved
ATC Code C01DA14
DrugBank ID DB01020
KEGG ID D00630
MeSH ID C030397
PubChem ID 27661
TTD Drug ID D0YS7D
NDC Product Code 50742-176; 51407-210; 55154-7292; 59651-539; 62135-586; 62175-107; 62175-128; 71335-2194; 0615-7767; 42677-101; 13668-104; 43063-313; 53002-1570; 62175-119; 62175-129; 63187-900; 68084-592; 70518-3585; 59651-541; 62135-588; 62175-362; 63187-700; 71335-2192; 55154-7291; 62135-587; 62175-361; 70518-1485; 0615-7768; 0228-2620; 23155-519; 50742-177; 51407-209; 51655-922; 59651-540; 63629-1823; 70518-2000; 70518-2692; 70518-3081; 0228-2631; 23155-628; 50742-175; 70934-972; 71335-0037; 0904-6450; 50090-4009; 51407-208; 62175-106; 42799-960; 63629-1424; 71335-1117; 0615-8043; 0615-8044; 13668-105; 13668-106; 23155-178; 42799-958; 42799-959; 68084-591; 70518-2956; 0904-6449; 42677-307; 50090-5686; 70518-2122; 70518-3132; 42677-102
UNII LX1OH63030
Synonyms isosorbide-5-mononitrate | isosorbide mononitrate | monocinque | 5-ISMN | isosorbide-5-nitrate | Elantan | Imdur | Ismo | Olicard-retard | Mono Mac 50D | Monoket | Mononit | Olicard 40 | 5-ISMN Durules | Monizid
Chemical Information
Molecular Formula C6H9NO6
CAS Registry Number 16051-77-7
SMILES C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Tachycardia02.03.02.0070.000070%Not Available
Tendon disorder12.01.07.019; 15.07.01.002--Not Available
Tension19.06.02.005--Not Available
Thirst14.03.02.007; 08.01.09.021--Not Available
Thrombocytopenia01.08.01.002--Not Available
Tinnitus17.04.07.004; 04.04.01.002--
Tooth disorder07.09.05.001--Not Available
Torticollis17.01.03.003; 15.05.04.003--Not Available
Tremor17.01.06.002--
Tympanic membrane perforation12.01.14.001; 04.05.04.001--Not Available
Upper respiratory tract infection22.07.03.011; 11.01.13.009--
Urethral disorder20.07.01.002--Not Available
Urinary tract disorder20.08.01.001--Not Available
Urinary tract infection20.08.02.001; 11.01.14.004--
Varicose vein24.10.04.001--Not Available
Vascular purpura23.06.01.008; 01.01.04.007; 24.07.06.011--Not Available
Vasospasm24.04.02.002--Not Available
Ventricular extrasystoles02.03.04.007--Not Available
Ventricular tachycardia02.03.04.010--
Vertigo17.02.12.002; 04.04.01.003--
Viral infection11.05.04.001--Not Available
Vision blurred17.17.01.010; 06.02.06.007--
Visual impairment06.02.10.013--Not Available
Vomiting07.01.07.003--
Weight decreased13.15.01.005--
Weight increased13.15.01.006--
Withdrawal syndrome19.07.06.023; 08.06.02.0120.000070%Not Available
Acute coronary syndrome24.04.04.011; 02.02.02.0150.000070%Not Available
Musculoskeletal stiffness15.03.05.027--Not Available
Musculoskeletal discomfort15.03.04.001--Not Available
The 7th Page    First    Pre   7 8    Next   Last    Total 8 Pages